Consider Decentralized Clinical Trial (DCT) Design From the Start

Date Published:

In this Q&A with Outsourcing Pharma, Signant Health’s Bill Byrom discusses the importance of designing protocols to meet the specific needs of decentralized clinical trial models rather than retrofitting. He shares why this study model benefits patients, the unique challenges, and what study teams need to do to succeed.

Read Dr. Byrom’s feature to learn tips for selectring the right wearable sensor and gain advice on evaluating remote patients accurately.

Download Now